Chapter 1. Introduction
|
1.1. Market Definition
|
1.2. Research Scope
|
1.2.1. Markets Covered
|
1.2.2. Years Considered for Study
|
|
|
Chapter 2. Research Methodology
|
2.1. Research Sources
|
2.1.1. Primary
|
2.1.2. Secondary
|
2.2. Market Size Estimation
|
|
|
Chapter 3. Executive Summary
|
3.1. Summary Snapshot Market Size and Forecast, 2018-2029
|
3.2. Preclinical In Vivo Imaging Solutions Market Share by Modality
Type, 2021 vs 2029 (USD Million)
|
3.3. Preclinical In Vivo Imaging Solutions Market Share by Reagent,
2021 vs 2029 (USD Million)
|
3.5. Preclinical In Vivo Imaging Solutions Market Share by Region,
2021 vs 2029 (USD Million)
|
|
|
Chapter 4. Key Insights
|
|
|
Chapter 5. Preclinical In Vivo Imaging
Solutions Market Segmentation & Impact Analysis
|
5.1. Preclinical In Vivo Imaging Solutions Market Indicators Analysis
|
5.1.1. Market Drivers Analysis
|
5.1.1.1.
Technological Advancements in the Field of Molecular Imaging
|
5.1.1.2. Increasing
Market Demand for Noninvasive Small-Animal Imaging Techniques
|
5.1.1.3. Growing Number of Public-Private
Initiatives and Funding to Support Preclinical Researches
|
5.1.2. Market Restraint Analysis
|
5.1.2.1. Strict
Regulations Governing Preclinical Research
|
5.2.
Regulatory Analysis
|
5.2.1. North America
|
5.2.1.1. U.S.
|
5.2.1.2. Canada
|
5.2.2. Europe
|
5.2.3. Asia Pacific
|
5.2.3.1. India
|
5.2.3.2. Japan
|
5.2.3.3. China
|
5.3. Technological Insights
|
5.4. COVID-19 Impact analysis on Preclinical In Vivo Imaging Solutions
Market
|
5.5.
Porter’s Five Forces Analysis
|
5.5.1. Bargaining Power of Buyers/Consumers
|
5.5.2. Bargaining Power of Suppliers
|
5.5.3. Threat of New Entrants
|
5.5.4. Threat of Substitute Products
|
5.5.5. Intensity of
Competitive Rivalry
|
5.6. Competitive Metric Space Analysis
|
|
|
Chapter 6. Preclinical In Vivo Imaging
Solutions Market, By Modality Type (Market Size and Forecast by Value - USD
Million, 2018 - 2029)
|
6.1. Preclinical In Vivo Imaging Solutions Market, By Modality Type
(Market Size and Forecast by Value - USD Million, 2021 & 2029)
|
6.1.1. Micro-CT
|
6.1.1.1.
Micro-CT Market Estimates and Forecast, 2019-2029 (USD Million)
|
6.1.1.2. Micro-CT Market Estimates and Forecast, By
Region, 2019-2029 (USD Million)
|
6.1.2. Micro-MRI
|
6.1.2.1. Micro-MRI
Market Estimates and Forecast, 2019-2029 (USD Million)
|
6.1.2.2. Micro-MRI
Market Estimates and Forecast, By Region, 2019-2029 (USD Million)
|
6.1.3. Micro-Ultrasound
|
6.1.3.1.
Micro-Ultrasound Market Estimates and Forecast, 2019-2029 (USD Million)
|
6.1.3.2.
Micro-Ultrasound Market Estimates and Forecast, By Region, 2019-2029 (USD
Million)
|
6.1.4. Nuclear Imaging Systems
|
6.1.4.1. Nuclear Imaging Systems Market Estimates
and Forecast, 2019-2029 (USD Million)
|
6.1.4.2. Nuclear Imaging Systems Market Estimates
and Forecast, By Region, 2019-2029 (USD Million)
|
6.1.4.3.
Micro-PET Systems
|
6.1.4.3.1. Micro-PET Systems
Market Estimates and Forecast, 2019-2029 (USD Million)
|
6.1.4.3.2.
Micro-PET Systems Market Estimates and Forecast, By Region, 2019-2029 (USD
Million)
|
6.1.4.4. Micro-Spect Systems
|
6.1.4.4.1. Micro-Spect Systems Market Estimates and Forecast, 2019-2029
(USD Million)
|
6.1.4.4.2. Micro-Spect Systems Market Estimates and Forecast, By
Region, 2019-2029 (USD Million)
|
6.1.4.5. Trimodality (Spect/PET/CT) Systems
|
6.1.4.5.1. Trimodality
(Spect/PET/CT) Systems Market Estimates and Forecast, 2019-2029 (USD Million)
|
6.1.4.5.2. Trimodality (Spect/PET/CT) Systems Market Estimates and
Forecast, By Region, 2019-2029 (USD Million)
|
6.1.5. Optical Imaging Systems
|
6.1.5.1. Optical
Imaging Systems Market Estimates and Forecast, 2019-2029 (USD Million)
|
6.1.5.2. Optical Imaging
Systems Market Estimates and Forecast, By Region, 2019-2029 (USD Million)
|
6.1.5.3. Bioluminescence/Fluorescence Imaging
Systems
|
6.1.5.3.1.
Bioluminescence/Fluorescence Imaging Systems Market Estimates and
Forecast, 2019-2029 (USD Million)
|
6.1.5.3.2. Bioluminescence/Fluorescence Imaging Systems Market
Estimates and Forecast, By Region, 2019-2029 (USD Million)
|
6.1.5.4. Standalone Fluorescence Imaging Systems
|
6.1.5.4.1. Standalone Fluorescence Imaging Systems Market Estimates
and Forecast, 2019-2029 (USD Million)
|
6.1.5.4.2. Standalone Fluorescence Imaging Systems Market Estimates
and Forecast, By Region, 2019-2029 (USD Million)
|
6.1.5.5. (Optical + X-Ray)/(Optical + CT) Systems
|
6.1.5.5.1.
(Optical + X-Ray)/(Optical + CT) Systems Market Estimates and Forecast,
2019-2029 (USD Million)
|
6.1.5.5.2. (Optical + X-Ray)/(Optical + CT) Systems Market Estimates
and Forecast, By Region, 2019-2029 (USD Million)
|
6.1.6. Other Imaging Systems
|
6.1.6.1. Other
Imaging Systems Market Estimates and Forecast, 2019-2029 (USD Million)
|
6.1.6.2. Other
Imaging Systems Market Estimates and Forecast, By Region, 2019-2029 (USD
Million)
|
|
|
Chapter 7. Preclinical In Vivo Imaging
Solutions Market, By Reagent (Market Size and Forecast by Value - USD
Million, 2018 - 2029)
|
7.1. Preclinical In Vivo Imaging Solutions Market, By Reagent (Market
Size and Forecast by Value - USD Million, 2021 & 2029)
|
7.1.1. Preclinical CT Contrast
Agents
|
7.1.1.1. Preclinical CT Contrast Agents Market Estimates
and Forecast, 2019-2029 (USD Million)
|
7.1.1.2. Preclinical CT Contrast Agents Market
Estimates and Forecast, By Region, 2019-2029 (USD Million)
|
7.1.2. Preclinical MRI Contrast
Agents
|
7.1.2.1. Preclinical MRI Contrast
Agents Market Estimates and Forecast, 2019-2029 (USD Million)
|
7.1.2.2. Preclinical
MRI Contrast Agents Market Estimates and Forecast, By Region, 2019-2029 (USD
Million)
|
7.1.3. Preclinical Nuclear
Imaging Reagents
|
7.1.3.1. Preclinical
Nuclear Imaging Reagents Market Estimates and Forecast, 2019-2029 (USD
Million)
|
7.1.3.2. Preclinical
Nuclear Imaging Reagents Market Estimates and Forecast, By Region, 2019-2029
(USD Million)
|
7.1.3.3. Preclinical PET Tracers
|
7.1.3.3.1. Preclinical PET Tracers
Market Estimates and Forecast, 2019-2029 (USD Million)
|
7.1.3.3.2. Preclinical PET Tracers Market Estimates and Forecast, By
Region, 2019-2029 (USD Million)
|
7.1.3.4. Preclinical Spect Probes
|
7.1.3.4.1. Preclinical Spect Probes Market Estimates and Forecast,
2019-2029 (USD Million)
|
7.1.3.4.2. Preclinical Spect Probes Market Estimates and Forecast, By
Region, 2019-2029 (USD Million)
|
7.1.4. Preclinical Optical
Imaging Reagents
|
7.1.4.1. Preclinical
Optical Imaging Reagents Market Estimates and Forecast, 2019-2029 (USD
Million)
|
7.1.4.2. Preclinical
Optical Imaging Reagents Market Estimates and Forecast, By Region, 2019-2029
(USD Million)
|
7.1.4.3. Bioluminescent Imaging Reagents
|
7.1.4.3.1. Bioluminescent
Imaging Reagents Market Estimates and Forecast, 2019-2029 (USD Million)
|
7.1.4.3.2. Bioluminescent Imaging Reagents Market Estimates and
Forecast, By Region, 2019-2029 (USD Million)
|
7.1.4.4. Fluorescent Imaging Reagents
|
7.1.4.4.1. Fluorescent Imaging Reagents Market Estimates and Forecast,
2019-2029 (USD Million)
|
7.1.4.4.2. Fluorescent Imaging Reagents Market Estimates and Forecast,
By Region, 2019-2029 (USD Million)
|
7.1.5. Preclinical Ultrasound
Contrast Agents
|
7.1.5.1. Preclinical Ultrasound Contrast Agents
Market Estimates and Forecast, 2019-2029 (USD Million)
|
7.1.5.2. Preclinical Ultrasound Contrast Agents
Market Estimates and Forecast, By Region, 2019-2029 (USD Million)
|
|
|
Chapter 8. Preclinical In Vivo Imaging
Solutions Market, By Region (Market Size and Forecast by Value - USD Million,
2018 - 2029)
|
8.1. Preclinical In Vivo Imaging Solutions Market, By Region (Market
Size and Forecast by Value - USD Million, 2021 & 2029)
|
8.2. North America
|
8.2.1. North America
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million)
|
8.2.2. North America
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million)
|
8.2.3. North America
Preclinical In Vivo Imaging Solutions Market, By Country, 2018-2029 (USD
Million)
|
8.2.4. U.S.
|
8.2.4.1. U.S.
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million)
|
8.2.4.2. U.S.
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million)
|
8.2.5. Canada
|
8.2.5.1. Canada
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million)
|
8.2.5.2. Canada
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million)
|
|
|
8.3. Europe
|
8.3.1. Europe Preclinical In
Vivo Imaging Solutions Market, By Modality Type, 2018-2029 (USD Million)
|
8.3.2. Europe Preclinical In
Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD Million)
|
8.3.3. Europe Preclinical In
Vivo Imaging Solutions Market, By Country, 2018-2029 (USD Million)
|
8.3.4. Germany
|
8.3.4.1. Germany
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million)
|
8.3.4.2. Germany
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million)
|
8.3.5. U.K.
|
8.3.5.1. U.K.
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million)
|
8.3.5.2. U.K.
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million)
|
8.3.6. France
|
8.3.6.1. France
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million)
|
8.3.6.2. France Preclinical
In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD Million)
|
8.3.7. Spain
|
8.3.7.1. Spain
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million)
|
8.3.7.2. Spain
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million)
|
8.3.8. Italy
|
8.3.8.1. Italy
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million)
|
8.3.8.2. Italy
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million)
|
8.3.9. Rest of Europe
|
8.3.9.1. Rest of
Europe Preclinical In Vivo Imaging Solutions Market, By Modality Type,
2018-2029 (USD Million)
|
8.3.9.2. Rest of Europe
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million)
|
|
|
8.4. Asia Pacific
|
8.4.1. Asia Pacific Preclinical
In Vivo Imaging Solutions Market, By Modality Type, 2018-2029 (USD Million)
|
8.4.2. Asia Pacific Preclinical
In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD Million)
|
8.4.3. Asia Pacific Preclinical
In Vivo Imaging Solutions Market, By Country, 2018-2029 (USD Million)
|
8.4.4. India
|
8.4.4.1. India
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million)
|
8.4.4.2. India
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million)
|
8.4.5. Japan
|
8.4.5.1. Japan
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million)
|
8.4.5.2. Japan
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million)
|
8.4.6. China
|
8.4.6.1. China
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million)
|
8.4.6.2. China
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million)
|
8.4.7. South Korea
|
8.4.7.1. South
Korea Preclinical In Vivo Imaging Solutions Market, By Modality Type,
2018-2029 (USD Million)
|
8.4.7.2. South Korea
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million)
|
8.4.8. Australia
|
8.4.8.1.
Australia Preclinical In Vivo Imaging Solutions Market, By Modality Type,
2018-2029 (USD Million)
|
8.4.8.2.
Australia Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029
(USD Million)
|
8.4.9. Rest of Asia Pacific
|
8.4.9.1. Rest of
Asia Pacific Preclinical In Vivo Imaging Solutions Market, By Modality Type,
2018-2029 (USD Million)
|
8.4.9.2. Rest of
Asia Pacific Preclinical In Vivo Imaging Solutions Market, By Reagent,
2018-2029 (USD Million)
|
|
|
8.5. Middle East & Africa
|
8.5.1. Middle East & Africa
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million)
|
8.5.2. Middle East &
AfricaPreclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029
(USD Million)
|
8.5.3. Middle East & Africa
Preclinical In Vivo Imaging Solutions Market, By Country, 2018-2029 (USD
Million)
|
8.5.4. UAE
|
8.5.4.1. UAE
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million)
|
8.5.4.2. UAE
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million)
|
8.5.5. Saudi Arabia
|
8.5.5.1. Saudi
Arabia Preclinical In Vivo Imaging Solutions Market, By Modality Type,
2018-2029 (USD Million)
|
8.5.5.2. Saudi Arabia
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million)
|
8.5.6. South Africa
|
8.5.6.1. South
Africa Preclinical In Vivo Imaging Solutions Market, By Modality Type,
2018-2029 (USD Million)
|
8.5.6.2. South
Africa Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029
(USD Million)
|
8.5.7. Rest of Middle East
& Africa
|
8.5.7.1. Rest of
Middle East & Africa Preclinical In Vivo Imaging Solutions Market, By
Modality Type, 2018-2029 (USD Million)
|
8.5.7.2. Rest of
Middle East & Africa Preclinical In Vivo Imaging Solutions Market, By
Reagent, 2018-2029 (USD Million)
|
|
|
8.6. Latin America
|
8.6.1. Latin America
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million)
|
8.6.2. Latin America Preclinical
In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD Million)
|
8.6.3. Latin America
Preclinical In Vivo Imaging Solutions Market, By Country, 2018-2029 (USD
Million)
|
8.6.4. Brazil
|
8.6.4.1. Brazil Preclinical In Vivo
Imaging Solutions Market, By Modality Type, 2018-2029 (USD Million)
|
8.6.4.2. Brazil
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million)
|
8.6.5. Mexico
|
8.6.5.1. Mexico
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million)
|
8.6.5.2. Mexico Preclinical
In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD Million)
|
8.6.6. Argentina
|
8.6.6.1. Argentina
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million)
|
8.6.6.2.
Argentina Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029
(USD Million)
|
8.6.7. Rest of Latin America
|
8.6.7.1. Rest of
Latin America Preclinical In Vivo Imaging Solutions Market, By Modality Type,
2018-2029 (USD Million)
|
8.6.7.2. Rest of
Latin America Preclinical In Vivo Imaging Solutions Market, By Reagent,
2018-2029 (USD Million)
|
|
|
Chapter 9. Competitive Landscape
|
9.1. Market Revenue Share by Manufacturers
|
9.2. Competitor’s Positioning
|
9.3. Strategy Benchmarking
|
9.3.1. Partnership &
Agreement
|
9.3.2. New Product Development
|
9.3.3. Mergers &
Acquisitions
|
9.3.4. Investment &
Expansion
|
9.4. Vendor Landscape
|
9.4.1. Distributors
|
9.4.2. North America
|
9.4.3. Europe
|
9.4.4. Asia Pacific
|
9.4.5. Middle East &
Africa
|
9.4.6. Latin America
|
9.5. Zettabyte Analytics Insights for Competitive Landscape
|
|
|
Chapter 10. Company Profiles
|
10.1. Agilent Technologies
|
10.1.1. Company Overview
|
10.1.2. Financials
|
10.1.3. Products Offered
|
10.1.4. Recent
Development
|
10.2.
Aspect Imaging Ltd.
|
10.2.1. Company Overview
|
10.2.2. Financials
|
10.2.3. Products Offered
|
10.2.4. Recent
Development
|
10.3. Berthold Technologies
|
10.3.1. Company Overview
|
10.3.2. Financials
|
10.3.3. Products Offered
|
10.3.4. Recent
Development
|
10.4. Biospace Lab S.A.
|
10.4.1. Company Overview
|
10.4.2. Financials
|
10.4.3. Products Offered
|
10.4.4. Recent
Development
|
10.5. Bruker Corporation
|
10.5.1. Company Overview
|
10.5.2. Financials
|
10.5.3. Products Offered
|
10.5.4. Recent
Development
|
10.6. Fujifilm Holdings Corporation
|
10.6.1. Company Overview
|
10.6.2. Financials
|
10.6.3. Products Offered
|
10.6.4. Recent
Development
|
10.7. Li-Cor Biosciences
|
10.7.1. Company Overview
|
10.7.2. Financials
|
10.7.3. Products Offered
|
10.7.4. Recent
Development
|
10.8.
Mediso Ltd.
|
10.8.1. Company Overview
|
10.8.2. Financials
|
10.8.3. Products Offered
|
10.8.4. Recent
Development
|
10.9. Milabs B.V.
|
10.9.1. Company Overview
|
10.9.2. Financials
|
10.9.3. Products Offered
|
10.9.4. Recent
Development
|
10.10. Miltenyi Biotec GmbH
|
10.10.1. Company Overview
|
10.10.2. Financials
|
10.10.3. Products Offered
|
10.10.4. Recent
Development
|
10.11. MR Solutions Ltd.
|
10.11.1. Company Overview
|
10.11.2. Financials
|
10.11.3. Products Offered
|
10.11.4. Recent
Development
|
10.12. New England Biolabs
|
10.12.1. Company Overview
|
10.12.2. Financials
|
10.12.3. Products Offered
|
10.12.4. Recent
Development
|
10.13. Perkinelmer, Inc.
|
10.13.1. Company Overview
|
10.13.2. Financials
|
10.13.3. Products Offered
|
10.13.4. Recent
Development
|
10.14. Thermo Fisher Scientific
|
10.14.1. Company Overview
|
10.14.2. Financials
|
10.14.3. Products Offered
|
10.14.4. Recent
Development
|
10.15. Trifoil Imaging
|
10.15.1. Company Overview
|
10.15.2. Financials
|
10.15.3. Products Offered
|
10.15.4. Recent
Development
|
10.16. UVP
|
10.16.1. Company Overview
|
10.16.2. Financials
|
10.16.3. Products Offered
|
10.16.4. Recent Development
|
10.17. Vieworks
|
10.17.1. Company Overview
|
10.17.2. Financials
|
10.17.3. Products Offered
|
10.17.4. Recent
Development
|
|
|
List of Tables
|
1
|
Preclinical In Vivo Imaging Solutions
Market, By Modality Type (Market Size and Forecast by Value - USD Million,
2021 & 2029)
|
2
|
Micro-CT Market Estimates and Forecast,
2019-2029 (USD Million)
|
3
|
Micro-CT Market Estimates and Forecast, By
Region, 2019-2029 (USD Million)
|
4
|
Micro-MRI Market Estimates and Forecast,
2019-2029 (USD Million)
|
5
|
Micro-MRI Market Estimates and Forecast, By
Region, 2019-2029 (USD Million)
|
6
|
Micro-Ultrasound Market Estimates and
Forecast, 2019-2029 (USD Million)
|
7
|
Micro-Ultrasound Market Estimates and
Forecast, By Region, 2019-2029 (USD Million)
|
8
|
Preclinical In Vivo Imaging Solutions
Market, By Reagent (Market Size and Forecast by Value - USD Million, 2021
& 2029)
|
9
|
Preclinical CT Contrast Agents Market
Estimates and Forecast, 2019-2029 (USD Million)
|
10
|
Preclinical CT Contrast Agents Market
Estimates and Forecast, By Region, 2019-2029 (USD Million)
|
11
|
Preclinical MRI Contrast Agents Market
Estimates and Forecast, 2019-2029 (USD Million)
|
12
|
Preclinical MRI Contrast Agents Market
Estimates and Forecast, By Region, 2019-2029 (USD Million)
|
13
|
Preclinical Nuclear Imaging Reagents Market
Estimates and Forecast, 2019-2029 (USD Million)
|
14
|
Preclinical Nuclear Imaging Reagents Market
Estimates and Forecast, By Region, 2019-2029 (USD Million)
|
15
|
North America Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million)
|
16
|
North America Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million)
|
17
|
North America Preclinical In Vivo Imaging
Solutions Market, By Country, 2018-2029 (USD Million)
|
18
|
U.S. Preclinical In Vivo Imaging Solutions
Market, By Modality Type, 2018-2029 (USD Million)
|
19
|
U.S. Preclinical In Vivo Imaging Solutions
Market, By Reagent, 2018-2029 (USD Million)
|
20
|
Canada Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million)
|
21
|
Canada Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million)
|
22
|
Europe Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million)
|
23
|
Europe Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million)
|
24
|
Europe Preclinical In Vivo Imaging
Solutions Market, By Country, 2018-2029 (USD Million)
|
25
|
Germany Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million)
|
26
|
Germany Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million)
|
27
|
U.K. Preclinical In Vivo Imaging Solutions
Market, By Modality Type, 2018-2029 (USD Million)
|
28
|
U.K. Preclinical In Vivo Imaging Solutions
Market, By Reagent, 2018-2029 (USD Million)
|
29
|
France Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million)
|
30
|
France Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million)
|
31
|
Spain Preclinical In Vivo Imaging Solutions
Market, By Modality Type, 2018-2029 (USD Million)
|
32
|
Spain Preclinical In Vivo Imaging Solutions
Market, By Reagent, 2018-2029 (USD Million)
|
33
|
Italy Preclinical In Vivo Imaging Solutions
Market, By Modality Type, 2018-2029 (USD Million)
|
34
|
Italy Preclinical In Vivo Imaging Solutions
Market, By Reagent, 2018-2029 (USD Million)
|
35
|
Rest of Europe Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million)
|
36
|
Rest of Europe Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million)
|
37
|
Rest of Europe Preclinical In Vivo Imaging
Solutions Market, By , 2018-2029 (USD Million)
|
38
|
Asia Pacific Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million)
|
39
|
Asia Pacific Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million)
|
40
|
Asia Pacific Preclinical In Vivo Imaging
Solutions Market, By , 2018-2029 (USD Million)
|
41
|
Asia Pacific Preclinical In Vivo Imaging
Solutions Market, By Country, 2018-2029 (USD Million)
|
42
|
India Preclinical In Vivo Imaging Solutions
Market, By Modality Type, 2018-2029 (USD Million)
|
43
|
India Preclinical In Vivo Imaging Solutions
Market, By Reagent, 2018-2029 (USD Million)
|
44
|
Japan Preclinical In Vivo Imaging Solutions
Market, By Modality Type, 2018-2029 (USD Million)
|
45
|
Japan Preclinical In Vivo Imaging Solutions
Market, By Reagent, 2018-2029 (USD Million)
|
46
|
China Preclinical In Vivo Imaging Solutions
Market, By Modality Type, 2018-2029 (USD Million)
|
47
|
China Preclinical In Vivo Imaging Solutions
Market, By Reagent, 2018-2029 (USD Million)
|
48
|
South Korea Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million)
|
49
|
South Korea Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million)
|
50
|
Australia Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million)
|
51
|
Australia Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million)
|
52
|
Rest of Asia Pacific Preclinical In Vivo
Imaging Solutions Market, By Modality Type, 2018-2029 (USD Million)
|
53
|
Rest of Asia Pacific Preclinical In Vivo
Imaging Solutions Market, By Reagent, 2018-2029 (USD Million)
|
54
|
Middle East & Africa Preclinical In
Vivo Imaging Solutions Market, By Modality Type, 2018-2029 (USD Million)
|
55
|
Middle East & AfricaPreclinical In Vivo
Imaging Solutions Market, By Reagent, 2018-2029 (USD Million)
|
56
|
Middle East & Africa Preclinical In
Vivo Imaging Solutions Market, By Country, 2018-2029 (USD Million)
|
57
|
UAE Preclinical In Vivo Imaging Solutions
Market, By Modality Type, 2018-2029 (USD Million)
|
58
|
UAE Preclinical In Vivo Imaging Solutions
Market, By Reagent, 2018-2029 (USD Million)
|
59
|
Saudi Arabia Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million)
|
60
|
Saudi Arabia Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million)
|
61
|
South Africa Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million)
|
62
|
South Africa Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million)
|
63
|
Rest of Middle East & Africa
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million)
|
64
|
Rest of Middle East & Africa Preclinical
In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD Million)
|
65
|
Latin America Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million)
|
66
|
Latin America Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million)
|
67
|
Latin America Preclinical In Vivo Imaging
Solutions Market, By Country, 2018-2029 (USD Million)
|
68
|
Brazil Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million)
|
69
|
Brazil Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million)
|
70
|
Mexico Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million)
|
71
|
Mexico Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million)
|
72
|
Argentina Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million)
|
73
|
Argentina Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million)
|
74
|
Rest of Latin America Preclinical In Vivo
Imaging Solutions Market, By Modality Type, 2018-2029 (USD Million)
|
75
|
Rest of Latin America Preclinical In Vivo
Imaging Solutions Market, By Reagent, 2018-2029 (USD Million)
|
76
|
Product Launch & Development in The
Preclinical In Vivo Imaging Solutions Market, 2018-2021
|
77
|
Recent Development in The Preclinical In
Vivo Imaging Solutions Market, 2018-2021
|
78
|
Partnership & Collaboration in The
Preclinical In Vivo Imaging Solutions Market, 2018-2021
|
79
|
Merger & Acquisition in The Preclinical
In Vivo Imaging Solutions Market, 2018-2021
|
|
|
List of Figures
|
1
|
Research Methodology
|
2
|
Summary Snapshot Market Size and Forecast,
USD Million, 2021 & 2029
|
3
|
Global Preclinical In Vivo Imaging
Solutions Market Segmentation & Impact Analysis
|
4
|
Regulatory Analysis
|
5
|
COVID-19 Impact analysis on Preclinical In
Vivo Imaging Solutions Market
|
6
|
Market Revenue Share by Manufacturers
|
7
|
Preclinical In Vivo Imaging Solutions
Market, By Modality Type (Market Size and Forecast by Value - USD Million,
2021 & 2029)
|
8
|
Preclinical In Vivo Imaging Solutions
Market, By Reagent (Market Size and Forecast by Value - USD Million, 2021
& 2029)
|
9
|
Preclinical In Vivo Imaging Solutions
Market, By Region (Market Size and Forecast by Value - USD Million, 2021
& 2029)
|